Department of Diagnostic Radiology and Neuroradiology, University Hospital, Ernst-Moritz-Arndt University, Ferdinand-Sauerbruch-Strasse, D-17487 Greifswald, Germany.
AJR Am J Roentgenol. 2010 Apr;194(4):1116-23. doi: 10.2214/AJR.09.2810.
The objective of our study was to use perfusion CT to prospectively monitor early vascular changes in tumor perfusion of pulmonary metastases after laser-induced thermotherapy (LITT) and to determine whether any of the perfusion parameters would predict technical success after therapy.
Twelve patients with histologically proven pulmonary metastases undergoing LITT were enrolled prospectively in this study. Perfusion CT was performed before treatment, 1 day after treatment, and 4-6 weeks after therapy, and tumor blood flow, tumor blood volume (TBV), mean transit time (MTT), and permeability of the capillary wall surface (capillary permeability-surface product) in 22 pulmonary metastases were calculated. Perfusion parameters at baseline and after LITT were compared. Measurement of tumor diameter on long-term follow-up CT was the gold standard with which perfusion CT results were compared for local control.
Median tumor blood flow, TBV, and capillary permeability-surface product had decreased significantly from baseline by 43%, 61%, and 73%, respectively, 1 day after LITT. Perfusion parameters obtained 4-6 weeks after treatment had not changed significantly compared with those obtained 1 day after therapy. There seems to be a good correlation between changes in perfusion CT parameters 1 day after therapy and local outcome, according to the Response Evaluation Criteria in Solid Tumors (RECIST), 1 year after therapy.
Perfusion CT of pulmonary metastases has potential in the assessment of early vascular changes that result from LITT and predicting technical success immediately after treatment. Tumors with perfusion measurements that had not changed after therapy indicated progressive disease.
本研究旨在使用灌注 CT 前瞻性监测激光诱导热疗(LITT)后肺转移瘤的早期血管变化,并确定任何灌注参数是否可预测治疗后的技术成功。
本研究前瞻性纳入 12 例经组织学证实的肺转移患者,这些患者接受 LITT 治疗。在治疗前、治疗后 1 天和治疗后 4-6 周进行灌注 CT 检查,计算 22 个肺转移瘤的肿瘤血流、肿瘤血容量(TBV)、平均通过时间(MTT)和毛细血管壁表面通透性(毛细血管通透性表面积产物)。比较治疗前后的灌注参数。长期随访 CT 上的肿瘤直径测量是金标准,与灌注 CT 结果进行比较以评估局部控制。
中位数肿瘤血流、TBV 和毛细血管通透性表面积产物在 LITT 后 1 天分别显著下降 43%、61%和 73%。治疗后 4-6 周获得的灌注参数与治疗后 1 天获得的灌注参数相比无显著变化。根据实体瘤反应评估标准(RECIST),治疗后 1 年,治疗后 1 天的灌注 CT 参数变化与局部疗效之间似乎存在良好的相关性。
肺转移瘤的灌注 CT 具有评估 LITT 后早期血管变化和预测治疗后即刻技术成功的潜力。治疗后灌注测量未发生变化的肿瘤提示进展性疾病。